Search Results

You are looking at 1 - 2 of 2 items for

  • Author or Editor: Jennifer S. Scherer x
  • Refine by Content Type: All x
Clear All Modify Search
Jennifer S. Scherer and Markus Bitzer

The United States ESRD population is aging. Patients over the age of 65 have the highest adjusted prevalence of ESRD (Figure 1) (1). As a result of these demographics, nephrology providers are now faced with the task of recognizing and treating not only the burdens of ESRD but also morbidities associated with geriatric syndromes (Table 1). Prognosis for the elderly encompasses survival as well as effects on quality of life (QOL), cognition, functional status, and time lost from being with family. Treatment choice and follow-up care should address these issues while considering the individual’s

Priority #3: ACCELERATE INNOVATION and expand patient choice. We need to develop future leaders in nephrology who can move the field forward scientifically and serve as advocates for our patients and our specialty.